Tilray Brands Inc. has expanded its presence in Italy with the launch of Tilray Medical Italia, rebranding its former entity FL Group. This move is part of Tilray’s strategy to strengthen its unified medical cannabis platform across Europe. The company is growing its portfolio of medical cannabis products authorized by the Italian Ministry of Health, supported by a partnership with Molteni Farmaceutici, a leading Italian pharmaceutical firm. Tilray Medical Italia now supplies pharmaceutical-grade medical cannabis to pharmacies throughout Italy, offering a range of medical cannabis flowers and oils available by prescription.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Tilray Brands Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: GNW9629670-en) on January 22, 2026, and is solely responsible for the information contained therein.